alpha anomeric bicyclo DNA conjugates (Alpha Anomeric)

N/A

Report date: 2025/03/14 16:53:58

Base Information

Drug Namealpha anomeric bicyclo DNA conjugates (Alpha Anomeric)
Drug Alias Nameoligonucleotide conjugates (Alpha Anomeric)
ClassificationBiologics
Mechanisms of ActionDMD gene modulators
TargetsDystrophin
Therapy Area/IndicationsMuscular Dystrophy, Duchenne
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryFrance
CombinationsNo
Global Highest StatusPreclinical
Highest Status in ChinaN/A
Originator CompaniesAlpha Anomeric Sas
China Registration ClassN/A

Develop Information

Active CompaniesAlpha Anomeric Sas
Inactive CompaniesN/A
Active IndicationsMuscular Dystrophy, Duchenne
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A